A groundbreaking shift in Canadian drug policy has occurred, as the government allow the use of psilocybin hallucinogens for therapeutic treatment. Before this, these substances were severely restricted, but a mounting body of evidence suggests they potentially offer benefits for psychological conditions like PTSD. This development represents a sub